Nigeria adopts actinium therapy for advanced precision cancer treatment

Nigeria has entered a new phase in cancer care with the introduction of Actinium-based radiopharmaceutical therapy, a targeted treatment designed to attack cancer cells while limiting damage to surrounding healthy tissues. According to The Nation, the therapy represents a significant advancement in the country’s capacity to provide precision oncology services.

Actinium therapy uses radioactive substances to deliver targeted radiation directly to cancer cells, making it particularly promising for patients with certain advanced or difficult-to-treat cancers. The development is expected to expand access to specialised cancer treatment in Nigeria and reduce the need for some patients to travel abroad for advanced care.

The new approach also underscores growing investment in modern oncology and personalised cancer management across the country, signalling a shift toward more sophisticated, homegrown treatment options.